London, June 20, 2018 – WINCHESTER MD LIMITED (“Winchester”or the “Company”) is pleased to announce that the Company has agreed to carry products from KannaSwiss (www.kannaswiss.com) the CBD product developer and manufacturer based in Kölliken, Switzerland. Marti Moshfeghi – COO of Winchester MD explains that “although HempElf.com is focused on importing high quality CBD products from USA, the KannaSwiss products were sufficiently high quality to meet the stringent standard for product selection at Hemp Elf.”
Hemp Elf will initially import full spectrum CBD oils, full spectrum water soluble CBD and CBD infused Swiss chocolates from the product range and will expand the range to over vapes when KannaSwiss release their proposed entrance into the vape market.
Winchester MA is pleased to be the first UK company to be supplying the KannaSwiss brand will look forward to promoting their quality products throughout 2018.
On Behalf of the Board,
About Winchester MD Limited
Winchester is a vertically integrated European cannabis company based out of London, UK. The Company was founded in 2018 with an initial focus on CBD Wellness through a revenue producing online retail platform Hemp Elf www.hempelf.com. The Company offers a variety of CBD products through its on line store and continues to develop and market new products in the CBD Wellness category. In 2019 the Company has expanded into other verticals in the cannabis sector including with the vision of becoming a global cannabis leader with cultivation, extraction, CBD wellness, R&D and clinics/education.
This release has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Therefore this release has not been subject to the procedures and controls which would apply if they were made or approved as a financial promotion by an authorised person. This release is not intended to be a financial promotion or offer to the public and the Company is not making an invitation to invest into the share capital of the Company.
Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended.
The Regulation Services Provider accepts no responsibility for the adequacy or accuracy of this release.